Healthcare Services

Rapid Diagnostics Market Outlook 2026–2030 Exploring New Business Opportunities

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Rapid Diagnostics Market Evolve From 2026 To 2030?

The rapid diagnostics market size has demonstrated substantial growth in recent years. It is forecast to increase from $36.08 billion in 2025 to $40.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. This historical expansion can be attributed to factors such as a heightened demand for swift clinical diagnostics, the broadening of decentralized healthcare settings, a growing incidence of chronic and infectious diseases, better accessibility to diagnostic tools, and the development of outpatient diagnostic services.

The rapid diagnostics market size is anticipated to undergo significant growth in the immediate future. It is projected to reach $64.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This expansion over the forecast period is driven by several factors, including escalating investments in molecular diagnostics, the increasing uptake of connected diagnostic devices, the broadening of home-based testing solutions, a heightened emphasis on personalized diagnostics, and the growing application of data-driven clinical workflows. Key trends anticipated during this period encompass the wider utilization of point-of-care diagnostic platforms, the surging adoption of molecular rapid testing, the expanding incorporation of digital result interpretation, the proliferation of portable diagnostic instruments, and an increased emphasis on providing early clinical decision support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24679&type=smp

What Key Drivers Are Influencing The Growth Of The Rapid Diagnostics Market?

The growing incidence of infectious disease is projected to boost the rapid diagnostics market in the future. Infectious disease refers to health conditions brought on by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can spread directly or indirectly between individuals. The increased occurrence of infectious diseases is fueled by greater global travel, contributing to faster transmission and higher infection rates. Rapid diagnostics assist in combating infectious diseases by enabling quick and accurate identification of pathogens, which permits timely treatment decisions, reduced transmission, and improved patient outcomes. For instance, in May 2025, The World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations focused on international public health, stated that global SARS-CoV-2 (the virus responsible for causing COVID-19, an infectious disease) activity had been rising since mid-February 2025. Based on data from sentinel sites, the test positivity rate reached 11%, a level last observed in July 2024. Thus, the increasing prevalence of infectious disease is propelling the rapid diagnostics market.

Which Segment Areas Are Covered In The Rapid Diagnostics Market Analysis?

The rapid diagnostics market covered in this report is segmented –

1) By Product Type: Kits, Reagents, Instruments, Other Product Types

2) By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms

3) By Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing

4) By Distribution Channel: Hospital Pharmacies, Brick and Mortar, E-Commerce, Other Distribution Channels

5) By End Use: Diagnostic Centers, Homecare Settings, Hospital Pharmacies, Other End Users

Subsegments:

1) By Kits: Lateral Flow Assay Kits, PCR Kits, Immunoassay Kits, Microfluidic Kits, Molecular Diagnostic Kits, Multiplex Kits

2) By Reagents: Enzymes, Buffers, Probes and Primers, Stains and Dyes, Antibodies, Calibration and Control Reagents

3) By Instruments: PCR Machines, Lateral Flow Readers, Immunoassay Analyzers, Microfluidic Analyzers, Automated Sample Processors, Biosensors

4) By Other Product Types: Software and Data Management Tools, Sample Collection Devices, Accessories and Consumables, Calibration Standards, Point-of-Care Devices

Which Trends Are Influencing The Rapid Diagnostics Market?

Leading companies within the rapid diagnostics market are concentrating on advancements and innovation, specifically rapid diagnostic testing tools, to improve diagnostic precision, decrease turnaround times, and enhance patient outcomes in point-of-care settings. These rapid diagnostic testing tools are medical devices capable of swiftly detecting specific diseases or conditions, typically providing results within minutes at the point of care. As an example, SEKISUI Diagnostics, a US-based medical diagnostics manufacturer, introduced the OSOM RSV Test in May 2025, a rapid diagnostic tool for identifying respiratory syncytial virus (RSV). This test is designed for use in professional healthcare settings and delivers results in just 15 minutes. It operates by employing a rapid immunochromatographic assay to qualitatively detect RSV nucleoprotein antigen, using anterior nasal swab specimens collected from patients displaying symptoms of respiratory infection. Its rapid turnaround time aids in timely and effective clinical decision-making.

Which Global Companies Are Actively Competing In The Rapid Diagnostics Market?

Major companies operating in the rapid diagnostics market are Johnson And Johnson Services Inc, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Fujirebio Holdings Inc, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA, LumiraDx Ltd

Read the full rapid diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Rapid Diagnostics Market?

North America was the largest region in the rapid diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Rapid Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24679&type=smp

Browse Through More Reports Similar to the Global Rapid Diagnostics Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Global Market Report

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Covid 19 Rapid Test Kits Global Market Report

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Rapid Strength Concrete Global Market Report

https://www.thebusinessresearchcompany.com/report/rapid-strength-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795